Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Anxo Pharmaceutical Co., Ltd. (6677) Financial Statements

Anxo Pharmaceutical Co., Ltd. Financial Overview

Anxo Pharmaceutical Co., Ltd.'s market cap is currently NT$1.17B. The company's EPS TTM is NT$-0.37; its P/E ratio is -55.41; and it has a dividend yield of 1.11%. Anxo Pharmaceutical Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 843.26MNT$ 895.32MNT$ 939.94MNT$ 866.27MNT$ 824.10M
Gross ProfitNT$ 300.18MNT$ 325.48MNT$ 396.93MNT$ 331.46MNT$ 331.66M
Operating IncomeNT$ -43.69MNT$ -56.42MNT$ 53.15MNT$ 5.95MNT$ 40.10M
EBITDANT$ 32.51MNT$ 33.37MNT$ 131.31MNT$ 84.96MNT$ 111.22M
Net IncomeNT$ -34.13MNT$ -57.21MNT$ 21.86MNT$ -12.56MNT$ 19.23M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 387.38MNT$ 382.83MNT$ 411.17MNT$ 262.03MNT$ 229.72M
Total AssetsNT$ 2.07BNT$ 2.11BNT$ 2.22BNT$ 1.97BNT$ 1.92B
Total DebtNT$ 734.98MNT$ 726.77MNT$ 787.84MNT$ 888.05MNT$ 883.44M
Net DebtNT$ 357.39MNT$ 367.86MNT$ 492.41MNT$ 646.73MNT$ 669.25M
Total LiabilitiesNT$ 958.70MNT$ 968.21MNT$ 1.02BNT$ 1.14BNT$ 1.09B
Stockholders' EquityNT$ 991.76MNT$ 1.02BNT$ 1.09BNT$ 724.86MNT$ 732.96M
Cash Flow
Free Cash FlowNT$ 7.74MNT$ 51.38MNT$ -60.70MNT$ 54.65MNT$ 44.45M
Operating Cash FlowNT$ 55.48MNT$ 111.97MNT$ -2.65MNT$ 71.27MNT$ 78.35M
Investing Cash FlowNT$ -55.22MNT$ 35.26MNT$ -179.24MNT$ -22.41MNT$ -37.36M
Financing Cash FlowNT$ 4.20MNT$ -83.75MNT$ 236.01MNT$ -21.72MNT$ -34.57M

Currency in TWD

Anxo Pharmaceutical Co., Ltd. Earnings and Revenue History

-500M0500M1B-10 %-5 %0 %5 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Anxo Pharmaceutical Co., Ltd. Liabilities to Assets

0800M1.6B2.4B40 %50 %60 %70 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Anxo Pharmaceutical Co., Ltd. Cash Flow

-300M-200M-100M0100M200M300M201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Anxo Pharmaceutical Co., Ltd. Forecast EPS vs Actual EPS

Earnings >